GlassScriptPhysician profile
Edward A Lin
NPI 1013234012
$5,632.31
in general payments reported to CMS, 2019-2025
41 companies · $778 in 2025
The $778 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $251 · 2021: $2,077 · 2022: $520 · 2023: $857 · 2024: $646 · 2025: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,280.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $1,480.08 | 2021-2025 | |
| Stryker Corporation | $657.86 | 2021-2025 | Mako, Axsos, Pangea |
| Globus Medical, INC. | $424.03 | 2022-2025 | Distal Radius Plate, Senza |
| Depuy Synthes Sales INC. | $423.51 | 2019-2022 | |
| Amgen INC. | $388.62 | 2019-2025 | Evenity, Prolia |
| Royal Biologics, INC. | $358.07 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $261.80 | 2019-2024 | Xiaflex |
| Orthofix Medical, INC. | $213.47 | 2023-2025 | Trinity Elite, Physio-Stim |
| Pacira Pharmaceuticals Incorporated | $132.12 | 2019-2025 | Exparel |
| Djo, LLC | $125.46 | 2022-2025 | Cmf |
| Zimmer Biomet Holdings, INC. | $125.05 | 2022 | |
| Acumed LLC | $106.51 | 2023 | |
| Endo USA, INC. | $84.72 | 2024-2025 | Xiaflex |
| Bioventus LLC | $76.72 | 2024-2025 | Exogen Ultrasound Bone Healing System, Xcell, Durolane |
| Dynasplint Systems INC. | $69.67 | 2025 | Dynasplint |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.